University of California, Irvine
General Surgery residency · Orange, CA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of California, Irvine's research in general surgery, which the program shares with other departments and affiliated hospitals.
About University of California, Irvineinstitution-wide general surgery research
General Surgery publications from University of California, Irvine and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
221
works per year
29th of 90 general surgery residency programs
+13.5%
2-year growth
49th of 88 general surgery residency programs
19.2%
in top 10% of field (works before 2025)
45th of 83 general surgery residency programs
49.9%
cited above world average
25th of 83 general surgery residency programs
Works per year · * 2026 so far
Surgery · 1,096
General Surgery research topics at University of California, Irvine
Papers in the window; each links to the list on OpenAlex.
Most cited at University of California, Irvine since 2024
All general surgery papers there on OpenAlex
- Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 studyDo‐Youn Oh et al. · The Lancet. Gastroenterology & hepatology · 2024 · PubMed · cited 325
- Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healingSergei Butenko et al. · Nature Communications · 2024 · PubMed · cited 230
- 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingJørn Herrstedt et al. · ESMO Open · 2024 · PubMed · cited 206
- Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trialAndrea Necchi et al. · The Lancet Oncology · 2024 · PubMed · cited 105
- TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomesYohann Loriot et al. · Annals of Oncology · 2024 · PubMed · cited 98
- Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IVRaman Puri et al. · Journal of clinical lipidology · 2024 · PubMed · cited 73
- Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trialRoger Li et al. · Nature Medicine · 2024 · PubMed · cited 70
- Management of Gallstone PancreatitisJames McDermott et al. · JAMA Surgery · 2024 · PubMed · cited 50
- Chest Wall Injury Society guidelines for surgical stabilization of rib fractures: Indications, contraindications, and timingZachary M. Bauman et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2025 · PubMed · cited 45
- Integrated Single-Cell Analysis Reveals Spatially and Temporally Dynamic Heterogeneity in Fibroblast States during Wound HealingAxel A. Almet et al. · Journal of Investigative Dermatology · 2024 · PubMed · cited 44